We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
-4.81%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$61.4M
AUM Growth
+$421K
Cap. Flow
-$3.84M
Cap. Flow %
-6.25%
Top 10 Hldgs %
36.09%
Holding
98
New
30
Increased
15
Reduced
28
Closed
20

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$2.57M
2
HCA icon
HCA Healthcare
HCA
+$2.24M
3
AAPL icon
Apple
AAPL
+$1.87M
4
ELV icon
Elevance Health
ELV
+$1.51M
5
GILD icon
Gilead Sciences
GILD
+$1.48M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$2.49M
2
AER icon
AerCap
AER
+$2.11M
3
WBA
Walgreens Boots Alliance
WBA
+$1.64M
4
SCHW
Charles Schwab
SCHW
+$1.53M
5
TXT icon
Textron
TXT
+$1.1M

Sector Composition

Rank Sector Weight
1 Healthcare 52.18%
2 Miscellaneous 15.51%
3 Technology 12.67%
4 Financials 6.92%
5 Communication Services 6.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCA icon
1
HCA Healthcare
HCA
$90.5B
$3.31M 5.4%
42,444
+32,125
+311% +$2.24M
ABBV icon
2
AbbVie
ABBV
$451B
$2.63M 4.28%
+46,029
New +$2.57M
BMY icon
3
Bristol-Myers Squibb
BMY
$136B
$2.22M 3.61%
34,687
-14,235
-29% -$898K
WBA
4
DELISTED
Walgreens Boots Alliance
WBA
$2.19M 3.57%
26,029
-20,529
-44% -$1.64M
OEF icon
5
CALL
iShares S&P 100 ETF
OEF
$20.5B
$2.09M 3.4%
+8,000
New +$698K
AAPL icon
6
Apple
AAPL
$4.67T
$2.04M 3.33%
+75,060
New +$1.87M
BMY icon
7
CALL
Bristol-Myers Squibb
BMY
$136B
$2.02M 3.3%
31,700
+15,700
+98% +$990K
JAZZ icon
8
Jazz Pharmaceuticals
JAZZ
$15.9B
$2M 3.26%
15,336
+4,292
+39% +$534K
AGN
9
DELISTED
Allergan plc
AGN
$1.83M 2.98%
6,822
-2,947
-30% -$844K
EW icon
10
Edwards Lifesciences
EW
$52B
$1.82M 2.97%
61,962
-8,520
-12% -$235K
ALDR
11
DELISTED
Alder Biopharmaceuticals
ALDR
$1.71M 2.78%
69,742
+32,986
+90% +$764K
GILD icon
12
Gilead Sciences
GILD
$181B
$1.6M 2.6%
17,379
+16,446
+1,763% +$1.48M
LRCX icon
13
Lam Research
LRCX
$378B
$1.57M 2.56%
189,980
+55,560
+41% +$404K
ELV icon
14
Elevance Health
ELV
$85.5B
$1.57M 2.55%
+11,268
New +$1.51M
MDCO
15
DELISTED
Medicines Co
MDCO
$1.47M 2.4%
46,338
-2,155
-4% -$70.4K
PANW icon
16
Palo Alto Networks
PANW
$303B
$1.4M 2.29%
51,606
-30,708
-37% -$755K
UHS icon
17
Universal Health Services
UHS
$10.1B
$1.4M 2.27%
11,187
-441
-4% -$49.6K
GOOGL icon
18
Alphabet (Google) Class A
GOOGL
$4.24T
$1.35M 2.2%
35,340
-10,620
-23% -$391K
AMZN icon
19
Amazon
AMZN
$2.87T
$1.31M 2.14%
44,160
-4,980
-10% -$141K
MSFT icon
20
Microsoft
MSFT
$3.81T
$1.31M 2.13%
23,654
+15,431
+188% +$809K
BLK icon
21
Blackrock
BLK
$180B
$1.11M 1.81%
3,272
+1,113
+52% +$353K
ABBV icon
22
CALL
AbbVie
ABBV
$451B
$1.04M 1.69%
+18,200
New +$1.01M
PYPL icon
23
PayPal
PYPL
$45.9B
$993K 1.62%
+25,731
New +$930K
HRTX icon
24
Heron Therapeutics
HRTX
$62M
$931K 1.52%
49,049
+2,111
+4% +$41.6K
VMC icon
25
Vulcan Materials
VMC
$35.6B
$901K 1.47%
8,530
-8,566
-50% -$812K
1
2 3 4

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q1 2016 Portfolio in Review

As of Q1 2016, Partner Investment Management held 98 positions worth $61.4M, up 0.69% from $61M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Partner Investment Management withdrew a net $3.84M in Q1 2016, closing 20 positions and reducing 28 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $2.49M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 58% a quarter earlier, followed by Miscellaneous and Technology.

Against the trend, Partner Investment Management opened a new position in AbbVie worth $2.63M.

  • Partner Investment Management's largest Q1 2016 buy was AbbVie: 46,029 shares worth $2.63M.
  • Partner Investment Management added most to HCA Healthcare in Q1 2016, an estimated $2.24M increase.
  • Partner Investment Management's biggest Q1 2016 reduction was Walgreens Boots Alliance, cutting an estimated $1.64M.
  • Partner Investment Management fully exited Teva Pharmaceuticals in Q1 2016, selling an estimated $2.49M.
  • Partner Investment Management's ten largest holdings make up 36% of its $61.4M portfolio in Q1 2016.
  • Partner Investment Management opened 30 new positions and closed 20 in Q1 2016.
  • Partner Investment Management's portfolio value rose 0.69% quarter-over-quarter to $61.4M.

Based on Partner Investment Management's 13F filing for Q1 2016, filed 16 May 2016.